Form 4: Limitless X Holdings Director Acquires Shares in Lieu of Compensation
SEC Form 4 Filing
Michael Albert Martin Braun, a director of Limitless X Holdings Inc., acquired 240,000 shares of common stock in consideration for accrued compensation.
Summary
- On January 13, 2025, Michael Albert Martin Braun, a director of Limitless X Holdings Inc., acquired 240,000 shares of common stock.
- The shares were issued in consideration for accrued compensation owed to Mr. Braun for his services as a director from January 11, 2023, through December 31, 2024.
- The acquisition was a direct transaction.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine transaction related to director compensation. It doesn't indicate significant positive or negative news about the company's performance.
Positives
- The acquisition reflects the company's commitment to compensating its directors.
Industry Context
Issuing shares in lieu of cash compensation is a common practice, especially for smaller companies or startups looking to conserve cash. It aligns the director's interests with those of the shareholders.
Stakeholder Impact
- Shareholders may experience slight dilution due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 01/11/2023 | Start date of director services for which compensation was accrued. |
| 12/31/2024 | End date of director services for which compensation was accrued. |
| 01/13/2025 | Date of the transaction (share acquisition). |
| 01/15/2025 | Date of signature on the Form 4. |
Keywords
Form 4, Director, Share Acquisition, Limitless X Holdings, LIMX, Compensation, Michael Albert Martin Braun
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.